Sunir Garg
BASICS
DESCRIPTION
Systemic hypertension leads to characteristic changes in the retina, choroid, and optic nerve. It can be divided into acute and chronic findings
Pregnancy Considerations
In women of child-bearing age with uncontrolled hypertension, check pregnancy status as these patients may have eclampsia/pre-eclampsia.
EPIDEMIOLOGY
Incidence
• 6.0% of patients in Beaver Dam Eye Study developed hypertensive retinopathy (1).
– Arterial narrowing was seen in 9.9% of patients.
– AV nicking was observed in 6.5% of patients (1).
Prevalence
• Occurs in 2–15% of people older than 40 years of age.
• Greater in African American than Caucasian population.
• No reliable association with age or gender (2).
RISK FACTORS
• Elevated systolic and diastolic blood pressure.
• Diabetes.
Genetics
There are likely multiple genetic factors that play a role in the development of hypertension.
GENERAL PREVENTION
• Maintenance of normotensive blood pressure.
• Antihypertensive medication.
• Regular blood pressure monitoring.
PATHOPHYSIOLOGY
• As blood pressure rises, retinal blood vessels undergo vasoconstriction.
• Over time, the blood vessel walls thicken.
• The blood–retinal barrier becomes compromised, leading to exudation and ischemia.
ETIOLOGY
• Essential hypertension
• Hypertension secondary to eclampsia, renal artery stenosis, and other systemic conditions
COMMONLY ASSOCIATED CONDITIONS
• Diabetes
• Hyperlipidemia
• Atherosclerosis
• Retinal artery macroaneurysm
• Branch vein or artery occlusion
• Stroke
• Cognitive decline
• Possible increased risk of coronary artery disease
• Age-related macular degeneration—possible link
• Glaucoma—possible link
DIAGNOSIS
HISTORY
• May or may not have diagnosis of hypertension/ elevated blood pressure.
• Many will have no history of eye disease.
PHYSICAL EXAM
• Findings from acute, accelerated or malignant, hypertension
– Fibrinoid necrosis of choroid/retinal pigment epithelium causes a deep, yellow – gray whitening in the acute phase
– Later these areas become hyperpigmented and are called Elschnig spots. Hyperpigmented flecks that are arranged in a linear fashion (following areas of choroidal infarction) are called Siegrist streaks.
– Optic disc edema—this can result from ischemia to the optic nerve to intracranial hypertension. must be present for diagnosis of malignant hypertension.
– Retinal hemorrhages, which may be ranging from mild intraretinal hemorrhages to severe subinternal limiting mimbane or subretinal hemorrhage
– Cotton wool spots
– Serous retinal detachment (4).
• Findings from chronic hypertension.
– Arteriolar narrowing—decreased artery to vein ratio (normal is 2:3).
– Copper wiring—light reflex widens and the vessel takes on the appearance of copper wire.
– Silver wiring occurs when the vessel becomes so narrow that blood flow through the artery is not visible on ophthalmoscopy.
– Arterior–venous nicking occurs when the artery compresses the vein in their common adventitial sheath (Gunn sign).
– Vein may be deflected as it crosses the arteriole (Salus sign).
– Microaneurysms
DIAGNOSTIC TESTS & INTERPRETATION
Lab
Initial lab tests
Blood pressure measurement.
Follow-up & special considerations
In patients with diabetes, controlling blood pressure decreases the risk of progression of retinopathy (3).
Imaging
Initial approach
• None needed unless secondary cause of blood pressure elevation is suspected.
• Fluorescein angiography may demonstrate microaneurysms, retinal telangiectasias, retinal/choroidal ischemia, and diffuse capillary and/or optic nerve leakage.
Follow-up & special considerations
• Close monitoring of both systolic and diastolic blood pressure is essential.
• Many acute changes may resolve with treatment of blood pressure.
Pathological Findings
• The Scheie classification of hypertensive retinopathy is the following:
– Grade 0: Normal fundus
– Grade 1: Mild arteriolar narrowing
– Grade 2: Obvious arteriolar narrowing with focal vessel irregularity
– Grade 3: Grade 2 with exudates or hemorrhages
– Grade 4: Grade 3 with optic disc edema
DIFFERENTIAL DIAGNOSIS
• Diabetic retinopathy
• Radiation retinopathy
• Juxtafoveal telangiectasis
• Retinal artery occlusions
• Vasculitis (lupus, lyme disease, sarcoidosis)
• Giant cell arteritis
TREATMENT
MEDICATION
First Line
Oral antihypertensive medications.
Second Line
Intravenous antihypertensive medication.
ADDITIONAL TREATMENT
General Measures
Treatment should be initiated with direction from the primary care physician.
Issues for Referral
• All patients with suspected hypertensive retinopathy should be referred to their primary doctor for further workup and treatment.
• Patients with signs of malignant/acute hypertension may require emergency inpatient stabilization.
IN-PATIENT CONSIDERATIONS
Initial Stabilization
Blood pressure lowering medications (see earlier).
Admission Criteria
Hypertensive emergency/malignant hypertension (diastolic blood pressure >120, with end-organ damage, which includes optic disc edema.
ONGOING CARE
FOLLOW-UP RECOMMENDATIONS
• Blood pressure should be closely monitored by the primary care doctor.
• Patients should undergo regular dilated fundus examination to rule out the above complications.
DIET
For salt-responsive patients, diets low in salt may aid in blood pressure lowering.
PATIENT EDUCATION
Inform patients of the need to maintain a normotensive blood pressure and to regularly take their blood pressure medications to reduce their risk of visual complications.
PROGNOSIS
Patients who maintain their blood pressures at a normotensive level, with drugs, diet or otherwise, usually maintain excellent vision.
COMPLICATIONS
• Retinal vein occlusion
• Retinal artery macroaneurysm (women > men)
• Retinal arterial occlusion
• Optic nerve ischemia/neuropathy
REFERENCES
1. Klein R, Klein BEK, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature. Trans Am Ophthalmol Soc 1997;95:329–348.
2. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004;351(22):2310–2317.
3. The UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J (Clin Res Ed) 1998;317:703–713.
4. Dellacroce JT, Vitale AT. Hypertension and the eye. Curr Opin Ophthalmol 2008;19(6):493–498.